Search

everythinglearnresearchcommunity

for

Search:↓

RHUPUS should be considered in children with deforming arthritis.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

SLE and DM can coexist but are rare and need careful evaluation.

Tph cells are linked to the severity of systemic lupus erythematosus.

A young woman with severe symptoms was diagnosed with SLE and improved significantly after treatment.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Different rheumatological diseases can cause specific skin problems.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Stem-cell therapy shows promise for skin conditions but needs more research.